Literature DB >> 2764110

Viability of the vascularly perfused, recirculating rat intestine and intestine-liver preparations.

H Hirayama1, X Xu, K S Pang.   

Abstract

Function and stability of vascularly perfused, recirculating in situ rat intestine (I) and intestine-liver (IL) preparations were evaluated in fasted and nonfasted rats because these techniques may be readily applied in drug metabolism studies. The rat intestine was perfused with blood medium (7.5 ml/min) via the superior mesenteric artery, with the venous outflow draining into the portal vein, which, together with hepatic arterial flow (2.5 ml/min), constituted the total blood flow (10 ml/min) to the liver. Maintenance of intestinal membrane integrity was observed. Rapid [14C]glucose absorption against a concentration gradient and a lack of [3H]-polyethylene glycol 4000 (PEG 4000, less than 4%) and Evans blue absorption by the recirculating I and IL preparations resulted after bolus injections of these markers into the pyloric end of the duodenum. Other indexes that revealed stable intestinal and liver functions were the following: preservation of reservoir perfusate volume, constancy in perfusion pressure, bile flow, and hemoglobin concentrations, evidence of intestinal glucose utilization and liver glucose production, and a lack of significant leakage of serum glutamic oxalic transaminase. The intestine and liver consumed oxygen at relatively constant rates, but the consumption rates for the fasted tissues (I or L) were significantly higher than those for nonfasted tissues. These results indicate that the vascularly perfused I and IL preparations were maintained in a viable and stable state for a 2-h perfusion period.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764110     DOI: 10.1152/ajpgi.1989.257.2.G249

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  Pharmacokinetic differences between pantoprazole enantiomers in rats.

Authors:  Zhiyong Xie; Yini Zhang; Haiyan Xu; Dafang Zhong
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

3.  Route-dependent metabolism of morphine in the vascularly perfused rat small intestine preparation.

Authors:  M M Doherty; K S Pang
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

4.  Acute increase, stimulated by prostaglandin E2, in glucose absorption via the sodium dependent glucose transporter-1 in rat intestine.

Authors:  B Scholtka; F Stümpel; K Jungermann
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

5.  Intestinal first-pass metabolism of eperisone in the rat.

Authors:  K Mihara; M Matsumura; E Yoshioka; K Hanada; H Nakasa; S Ohmori; M Kitada; H Ogata
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

6.  Kinetic analysis of the drug permeation process across the intestinal epithelium.

Authors:  S Yamashita; M Yoshida; Y Taki; T Sakane; T Nadai
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

7.  Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.

Authors:  K Tabata; K Yamaoka; T Fukuyama; T Nakagawa
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

8.  Double luminal and vascular perfusion of chicken jejunum: studies on 3-O-methyl-D-glucose absorption.

Authors:  T Roig; M P Vinardell; J Ruberté; E Fernández
Journal:  Pflugers Arch       Date:  1993-12       Impact factor: 3.657

Review 9.  Beyond glucose: alternative sources of energy in glioblastoma.

Authors:  John L Caniglia; Anvesh Jalasutram; Swapna Asuthkar; Joseph Sahagun; Simon Park; Aditya Ravindra; Andrew J Tsung; Maheedhara R Guda; Kiran K Velpula
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.